高分辨CT增强扫描联合双时相PET/CT显像对肺炎型肺癌的诊断价值

赵建; 张巍; 范承林; 马万辉; 张毅; 黎海涛

doi:10.16016/j.1000-5404.201801239

您当前的位置：

首页 >

文章列表页 >

高分辨CT增强扫描联合双时相PET/CT显像对肺炎型肺癌的诊断价值

临床医学 | 更新时间：2026-01-09

- 高分辨CT增强扫描联合双时相PET/CT显像对肺炎型肺癌的诊断价值
- Diagnostic value of two-phase PET-CT combined with enhanced CT for pneumonia type carcinoma of lung
- 第三军医大学学报 2018年40卷第13期页码：1242-1246
- 作者机构：
  
  1.614000 四川乐山，武警四川省总队医院放射科
  2.400038 重庆，陆军军医大学(第三军医大学)第一附属医院放射科
- 作者简介：
  
  [黎海涛，E-mail：13883818704@163.com LI Haitao, E-mail: 13883818704@163.com
- 基金信息：
- DOI：10.16016/j.1000-5404.201801239
  中图分类号： R730.42; R734.2; R814.42
- 收稿：2018-01-16，
  
  修回：2018-04-02，
  
  纸质出版：2018-07-15
- 稿件说明：
移动端阅览
赵建, 张巍, 范承林, 等. 高分辨CT增强扫描联合双时相PET/CT显像对肺炎型肺癌的诊断价值[J]. 第三军医大学学报, 2018,40(13):1242-1246.

Jian ZHAO, Wei ZHANG, Chenglin FAN, et al. Diagnostic value of two-phase PET-CT combined with enhanced CT for pneumonia type carcinoma of lung[J]. Journal of Third Military Medical University, 2018, 40(13): 1242-1246.
赵建, 张巍, 范承林, 等. 高分辨CT增强扫描联合双时相PET/CT显像对肺炎型肺癌的诊断价值[J]. 第三军医大学学报, 2018,40(13):1242-1246. DOI： 10.16016/j.1000-5404.201801239.

Jian ZHAO, Wei ZHANG, Chenglin FAN, et al. Diagnostic value of two-phase PET-CT combined with enhanced CT for pneumonia type carcinoma of lung[J]. Journal of Third Military Medical University, 2018, 40(13): 1242-1246. DOI： 10.16016/j.1000-5404.201801239.

摘要

目的

探讨肺炎型肺癌的

F-FDG PET/CT表现特征，评价胸部增强CT联合双时相

F-FDG PET/CT显像对肺炎型肺癌的诊断价值。

方法

分析武警四川省总队医院放射科2013年1月至2017年6月收集的19例肺炎型肺癌患者的

F-FDG PET/CT及胸部增强CT临床资料[男性12例，女性7例，年龄30~79(58.8±13.2)岁，体质量43~82(57.3±11.4)kg

]

，比较采用CT增强检查、单时相PET/CT、单时相PET/CT联合增强CT、双时相PET/CT、双时相PET/CT联合增强CT对肺炎型肺癌的诊断效能。

结果

依据病理结果为金标准，CT增强组正确诊断5例(

26.3%)；单时相PET/CT正确诊断组12例(63.2%)；单时相PET/CT联合增强CT组正确诊断15例(78.9%)；双时相PET/CT正确诊断组14例(73.7%)；双时相PET/CT联合增强CT检查组正确诊断18例(94.7%)。经χ

检验，差异有统计学意义(χ

=22.697，

＜0.05)。采用Fisher确切概率法比较5组间的诊断正确率，结果显示仅有双时相PET/CT联合增强CT组与增强CT组差异存在统计学意义(

＜0.005)，即双时相PET/CT联合增强CT的诊断正确率高于增强CT组，其他组不能表现出差异。

结论

双时相

F-FDG PET/CT联合增强CT可以提高诊断肺炎型肺癌的正确率。

Abstract

Objective

To investigate the

F-FDG PET/CT imaging features of pneumonia type carcinoma of lung (PTCL)

and to assess the diagnostic value of two-phase

F-FDG PET/CT combined with enhanced CT for PTCL.

Methods

The findings of

F-FDG PET/CT and chest enhanced CT scanning of 19 PTCL cases admitted in our hospital from January 2013 to June 2017 were collected and analyzed in this study. Among the 19 PTCL patients

there were 12 males and 7 females

at a mean age of 58.8±13.2 (30~79) years

and a mean body weight of 57.3±11.4 (43~82)kg. The diagnostic efficacy of enhanced CT

one-phase PET/CT

one-phase PET/CT combined with the enhanced CT

two-phase PET/CT

and two-phase PET/CT combined with enhanced CT were compared.

Results

The pathological results were regarded as the gold standard. It was only 5 cases diagnosed correctly through enhanced CT

with a positive rate of 26.3%

only 12 cases (63.2%) by one-phase

F-FDG PET/CT

15 cases (78.9%) by one-phase PET/CT combined with enhanced CT

14 cases (73.7%) by two-phase

F-FDG PET/CT

and 18 cases (94.7%) by two-phase

F-FDG PET/CT combined with enhanced CT.

Chi

-square test showed statistical differences were observed in the diagnostic rate among the 5 methods (

Chi

-square=22.697

0.05). Then Fisher's exact probability test indicated that significant difference in diagn

ostic accuracy was only seen between two-phase PET/CT combined with enhanced CT and enhanced CT

with the former method having higher accuracy (

0.005).

Conclusion

Two-phase

F-FDG PET/CT combined with enhanced CT can improve the diagnostic accuracy for PTCL.

关键词

Keywords

references

MIR E, SAREEN R,KULSHRESHTHA R, et al. Bronchioloalveolar cell carcinoma presenting as a "non-resolving consolidation" for two years[J]. Pneumonol Alergol Pol, 2015, 83(3): 208-211.DOI:10.5603/PiAP.2015.0033.

黎海涛, 王健, 陈伟, 等. 18 F-FDG PET/CT显像在恶性肿瘤临床诊断中的应用[J ] .第三军医大学学报, 2006, 28(7):718-720.

LI H T, WANG J, CHEN W, et al. Clinical value of F-FDG PET/CT in diagnosis of malignant tumors[J]. J Third Mil Med Univ, 2006, 28(7):718-720.

崔社怀, 金榕兵, 曹国强, 等. FDG-PET对非小细胞肺癌分期的意义[J].第三军医大学学报, 2005, 27(15):1576-1578.

CUI S H, JIN R B, CAO G Q, et al. Significance of FDG-PET for staging of non-small cell lung cancer[J]. J Third Mil Med Univ, 2005, 27(15):1576-1578.

TRAVIS W D, BRAMBILLA E, NOGUCHI M, et al. Inter-national association for the study of lung cancer /American Thoracic Society/European Respiratory Society:international multidisciplinary classification of lung adenocarcinoma:executive summary[J].Proc Am Thorac Soc, 2011, 8(5):381-385.DOI:10.1097/JTO.0b013e318206a221.

AUSTIN J H, GARG K, ABERLE D, et al. Radiologic implications of the 2011 classification of adenocarcinoma of the lung[J]. Radiology, 2013, 266(1): 62-71.DOI: 10.1148/radiol.12120240.

张珣, 徐丽莹, 夏冰.肺炎型肺癌的CT特点与病理对照分析[J].临床放射学杂志, 2015, 34(8):1220-1223.

ZHANG X, XU L Y, XIA B.Pneumonia type carcinoma of lung:CT pathologic correlation[J].J Clin Radiol, 2015, 34 (8):1220-1223.DOI:10.13437/j.cnki.jcr.2015.08.010.

LIU X, ADAMS A L.Mucoepidermoid carcinoma of the bronchus:a review[J]. Arch Pathol Lab Med, 2007, 131(9):1400-1404.DOI: 10.1043/1543-2165(2007)131[1400: MCOTBA]2.0.CO; 2.

FISCHER B M, MORTENSEN J. The future in diagnosis and staging of lung cancer: positron emission tomography[J]. Respiration, 2006, 73(3):267-276. DOI:10.1159/0000 92080.

SAHINER I, VURAL G U. Positron emission tomography/computerized tomography in lung cancer[J]. Quantit Imag Med Surg, 2014, 4(3): 195-206.DOI: 10.3978/j.issn.2223-4292.2014.03.05.

BRADLEY J, BAE K, CHOI N, et al.A phase II comparative study of gross tumor volume definition with or withoutPET/CTfusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of radiation therapy oncology group (RTOG) 0515[J]. Int J Radiat Oncol Biol Phys, 2012, 82(1): 435-441.DOI: 10.1016/j.ijrobp.2010.09.033.

MACMANUS M P, HICKS R J.PET scanning in lung cancer: current status and future directions[J].Semin Surg Oncol, 2010, 21(3):149-155.DOI: 10.1002/ssu.10032.

GUPTA G, GANDHI J S, SHARMA A, et al.A study of the pathological outcome of positron emission tomography-computed tomography 2(- 18 F)-fluro-2-deoxy-D-glucose avid lesion:a 5 years retrospective study[J ] . J Cancer Res Ther, 2017, 13(6):1000-1006.DOI: 10.4103/0973-1482.165874.

UESAKA D, DEMURA Y, ISHIZAKI T, et al.Evaluation of dual-time-point 18 F-FDG PET for staging in patients with lung cancer[J ] .J Nul Med, 2008, 49(10):1577-1578.DOI: 10.2967/jnumed.108.051250.

ALKHAWALDEH K, BIERSACK H J, HENKE A, et al. Impact of dual-time-point F-18 FDG PET/CT in the assessment of pleural effusion in patients with non-small-cell lung cancer[J]. Clin Nucl Med, 2011, 36(6):423-428.DOI: 10.1097/RLU.0b013e3182173823.

BARGER R L JR, NANDALUR K R. Diagnostic performance of dual-time 18 F-FDG PET in the diagnosis of pulmonary nodules: a meta-analysis[J ] . Acad Radiol, 2012, 19(2):153-158. DOI: 10.1016/j.acra.2011.10.009.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据